Sarcopenia and Its Impact on Anti-obesity Drug Development Sarcopenic obesity, a condition defined by the co-existence of obesity and sarcopenia (loss of muscle mass and function) has emerged as a public health concern, particularly in the aging population
Tirzepatide has emerged as a game-changing option for individuals struggling with weight loss, demonstrating clinical efficacy that surpasses traditional single-hormone treatments
doi: 10.1038/s41598-019-39537-z 78 LiuYWangYHaoSQinYWuY
PMID: 41978422 Chem Biol Interact Integrated network pharmacology, bioinformatics, and experiment analysis to decipher the molecular mechanism of Salidroside on Gastric cancer via targeting NCOA4-mediated ferritinophagy
Diarrhea Diarrhea is another common issue, affecting up to 23% of Zepbound users and 17% of Mounjaro users
Cooper C, Arva NC, Lee C, Yelamos O, Obregon R, Sholl LM, et al